Vimarsana
Biggest News Aggregation in the World

Page 30 - Services Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Services Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Services Research Today - Breaking & Trending Today

Continuity of care needed from the 'front of the pathway' to the back - Vimarsana News

Continuity of care needed from the 'front of the pathway' to the back

After undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, new University of Otago research shows

2 August 2023 Continuity of care needed from the 'front of the pathway' to the back, News, University of Otago, New Zealand - Vimarsana News

2 August 2023 Continuity of care needed from the 'front of the pathway' to the back, News, University of Otago, New Zealand

After undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, new University of Otago research shows.

Study cited by Texas judge in abortion-pill case under investigation - Vimarsana News

Study cited by Texas judge in abortion-pill case under investigation

A judge leaned on a study that was designed, funded and produced by the research arm of one of the most powerful anti-abortion groups.

Baxter Launches PERCLOT Absorbable Hemostatic Powder - Vimarsana News

Baxter Launches PERCLOT Absorbable Hemostatic Powder

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding ...

Baxter Launches PERCLOT Absorbable Hemostatic Powder - Vimarsana News

Baxter Launches PERCLOT Absorbable Hemostatic Powder

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products ...